Compile Data Set for Download or QSAR
Report error Found 44 Enz. Inhib. hit(s) with all data for entry = 10415
TargetPhosphatidylinositol 4-kinase(Cryptosporidium parvum (strain Iowa II))
Novartis

WIPO
LigandPNGBDBM533768(WO2022079616, Example 1.05 | Isobutyl 5-(3-(4-carb...)
Affinity DataIC50: 100nMAssay Description: Baculovirus expression and purification of C. parvum phosphatidylinositol 4-kinase: The full-length coding sequence of C. parvum PI(4)K (cgd8_4500, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2022
Entry Details
WIPO WO2022079616

TargetPhosphatidylinositol 4-kinase(Cryptosporidium parvum (strain Iowa II))
Novartis

WIPO
LigandPNGBDBM533767(WO2022079616, Example 1.04 | 2-(Methylthio)ethyl 5...)
Affinity DataIC50: 100nMAssay Description: Baculovirus expression and purification of C. parvum phosphatidylinositol 4-kinase: The full-length coding sequence of C. parvum PI(4)K (cgd8_4500, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2022
Entry Details
WIPO WO2022079616

TargetPhosphatidylinositol 4-kinase(Cryptosporidium parvum (strain Iowa II))
Novartis

WIPO
LigandPNGBDBM533770(WO2022079616, Example 1.07 | Thiazol-5-ylmethyl 5-...)
Affinity DataIC50: 100nMAssay Description: Baculovirus expression and purification of C. parvum phosphatidylinositol 4-kinase: The full-length coding sequence of C. parvum PI(4)K (cgd8_4500, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2022
Entry Details
WIPO WO2022079616

TargetPhosphatidylinositol 4-kinase(Cryptosporidium parvum (strain Iowa II))
Novartis

WIPO
LigandPNGBDBM533769(WO2022079616, Example 1.06 | 2-Methoxy-2-oxoethyl ...)
Affinity DataIC50: 100nMAssay Description: Baculovirus expression and purification of C. parvum phosphatidylinositol 4-kinase: The full-length coding sequence of C. parvum PI(4)K (cgd8_4500, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2022
Entry Details
WIPO WO2022079616

TargetPhosphatidylinositol 4-kinase(Cryptosporidium parvum (strain Iowa II))
Novartis

WIPO
LigandPNGBDBM533863(WO2022079616, Example 2.1)
Affinity DataIC50: 100nMAssay Description: Baculovirus expression and purification of C. parvum phosphatidylinositol 4-kinase: The full-length coding sequence of C. parvum PI(4)K (cgd8_4500, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2022
Entry Details
WIPO WO2022079616

TargetPhosphatidylinositol 4-kinase(Cryptosporidium parvum (strain Iowa II))
Novartis

WIPO
LigandPNGBDBM533771(WO2022079616, Example 1.08 | 2-Morpholinoethyl 5-(...)
Affinity DataIC50: 100nMAssay Description: Baculovirus expression and purification of C. parvum phosphatidylinositol 4-kinase: The full-length coding sequence of C. parvum PI(4)K (cgd8_4500, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2022
Entry Details
WIPO WO2022079616

TargetPhosphatidylinositol 4-kinase(Cryptosporidium parvum (strain Iowa II))
Novartis

WIPO
LigandPNGBDBM533864(WO2022079616, Example 3.1 | Methyl 2-chloro-5-(N-m...)
Affinity DataIC50: 100nMAssay Description: Baculovirus expression and purification of C. parvum phosphatidylinositol 4-kinase: The full-length coding sequence of C. parvum PI(4)K (cgd8_4500, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2022
Entry Details
WIPO WO2022079616

TargetPhosphatidylinositol 4-kinase(Cryptosporidium parvum (strain Iowa II))
Novartis

WIPO
LigandPNGBDBM533773(WO2022079616, Example 1.10 | 2,2,2-Trifluoroethyl ...)
Affinity DataIC50: 100nMAssay Description: Baculovirus expression and purification of C. parvum phosphatidylinositol 4-kinase: The full-length coding sequence of C. parvum PI(4)K (cgd8_4500, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2022
Entry Details
WIPO WO2022079616

TargetPhosphatidylinositol 4-kinase(Cryptosporidium parvum (strain Iowa II))
Novartis

WIPO
LigandPNGBDBM533772(WO2022079616, Example 1.09 | Ethyl 5-(3-(4-carbamo...)
Affinity DataIC50: 100nMAssay Description: Baculovirus expression and purification of C. parvum phosphatidylinositol 4-kinase: The full-length coding sequence of C. parvum PI(4)K (cgd8_4500, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2022
Entry Details
WIPO WO2022079616

TargetPhosphatidylinositol 4-kinase(Cryptosporidium parvum (strain Iowa II))
Novartis

WIPO
LigandPNGBDBM533865(WO2022079616, Example 4.1 | Methyl 2-(3-(4-carbamo...)
Affinity DataIC50: 100nMAssay Description: Baculovirus expression and purification of C. parvum phosphatidylinositol 4-kinase: The full-length coding sequence of C. parvum PI(4)K (cgd8_4500, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2022
Entry Details
WIPO WO2022079616

TargetPhosphatidylinositol 4-kinase(Cryptosporidium parvum (strain Iowa II))
Novartis

WIPO
LigandPNGBDBM533775(WO2022079616, Example 1.12 | 2-(Dimethylamino)-2-o...)
Affinity DataIC50: 100nMAssay Description: Baculovirus expression and purification of C. parvum phosphatidylinositol 4-kinase: The full-length coding sequence of C. parvum PI(4)K (cgd8_4500, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2022
Entry Details
WIPO WO2022079616

TargetPhosphatidylinositol 4-kinase(Cryptosporidium parvum (strain Iowa II))
Novartis

WIPO
LigandPNGBDBM533774(WO2022079616, Example 1.11 | 2-Methoxyethyl 5-(3-(...)
Affinity DataIC50: 100nMAssay Description: Baculovirus expression and purification of C. parvum phosphatidylinositol 4-kinase: The full-length coding sequence of C. parvum PI(4)K (cgd8_4500, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2022
Entry Details
WIPO WO2022079616

TargetPhosphatidylinositol 4-kinase(Cryptosporidium parvum (strain Iowa II))
Novartis

WIPO
LigandPNGBDBM533782(WO2022079616, Example 1.13 | isopropyl 5-(3-(4-car...)
Affinity DataIC50: 100nMAssay Description: Baculovirus expression and purification of C. parvum phosphatidylinositol 4-kinase: The full-length coding sequence of C. parvum PI(4)K (cgd8_4500, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2022
Entry Details
WIPO WO2022079616

TargetPhosphatidylinositol 4-kinase(Cryptosporidium parvum (strain Iowa II))
Novartis

WIPO
LigandPNGBDBM533786(WO2022079616, Example 1.15 | rac-(Tetrahydrofuran-...)
Affinity DataIC50: 100nMAssay Description: Baculovirus expression and purification of C. parvum phosphatidylinositol 4-kinase: The full-length coding sequence of C. parvum PI(4)K (cgd8_4500, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2022
Entry Details
WIPO WO2022079616

TargetPhosphatidylinositol 4-kinase(Cryptosporidium parvum (strain Iowa II))
Novartis

WIPO
LigandPNGBDBM533790(WO2022079616, Example 1.16 | Methyl 2-chloro-5-(N-...)
Affinity DataIC50: 100nMAssay Description: Baculovirus expression and purification of C. parvum phosphatidylinositol 4-kinase: The full-length coding sequence of C. parvum PI(4)K (cgd8_4500, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2022
Entry Details
WIPO WO2022079616

TargetPhosphatidylinositol 4-kinase(Cryptosporidium parvum (strain Iowa II))
Novartis

WIPO
LigandPNGBDBM533793(WO2022079616, Example 1.18 | 2-Chloro-5-(N-methyl-...)
Affinity DataIC50: 100nMAssay Description: Baculovirus expression and purification of C. parvum phosphatidylinositol 4-kinase: The full-length coding sequence of C. parvum PI(4)K (cgd8_4500, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2022
Entry Details
WIPO WO2022079616

TargetPhosphatidylinositol 4-kinase(Cryptosporidium parvum (strain Iowa II))
Novartis

WIPO
LigandPNGBDBM533791(WO2022079616, Example 1.17 | t-Butyl 2-chloro-5-(N...)
Affinity DataIC50: 100nMAssay Description: Baculovirus expression and purification of C. parvum phosphatidylinositol 4-kinase: The full-length coding sequence of C. parvum PI(4)K (cgd8_4500, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2022
Entry Details
WIPO WO2022079616

TargetPhosphatidylinositol 4-kinase(Cryptosporidium parvum (strain Iowa II))
Novartis

WIPO
LigandPNGBDBM533812(WO2022079616, Example 1.19 | 2-Morpholinoethyl 2-c...)
Affinity DataIC50: 100nMAssay Description: Baculovirus expression and purification of C. parvum phosphatidylinositol 4-kinase: The full-length coding sequence of C. parvum PI(4)K (cgd8_4500, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2022
Entry Details
WIPO WO2022079616

TargetPhosphatidylinositol 4-kinase(Cryptosporidium parvum (strain Iowa II))
Novartis

WIPO
LigandPNGBDBM533813(WO2022079616, Example 1.21 | Methyl 2-chloro-5-(N-...)
Affinity DataIC50: 100nMAssay Description: Baculovirus expression and purification of C. parvum phosphatidylinositol 4-kinase: The full-length coding sequence of C. parvum PI(4)K (cgd8_4500, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2022
Entry Details
WIPO WO2022079616

TargetPhosphatidylinositol 4-kinase(Cryptosporidium parvum (strain Iowa II))
Novartis

WIPO
LigandPNGBDBM533860(WO2022079616, Example 1.25 | Methyl 5-(3-(4-carbam...)
Affinity DataIC50: 100nMAssay Description: Baculovirus expression and purification of C. parvum phosphatidylinositol 4-kinase: The full-length coding sequence of C. parvum PI(4)K (cgd8_4500, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2022
Entry Details
WIPO WO2022079616

TargetPhosphatidylinositol 4-kinase(Cryptosporidium parvum (strain Iowa II))
Novartis

WIPO
LigandPNGBDBM533764(WO2022079616, Example 1.01 | N-(4-cyanophenyl)-N-m...)
Affinity DataIC50: 100nMAssay Description: Baculovirus expression and purification of C. parvum phosphatidylinositol 4-kinase: The full-length coding sequence of C. parvum PI(4)K (cgd8_4500, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2022
Entry Details
WIPO WO2022079616

TargetPhosphatidylinositol 4-kinase(Cryptosporidium parvum (strain Iowa II))
Novartis

WIPO
LigandPNGBDBM533766(WO2022079616, Example 1.03 | 5-(3-(4-Carbamoylphen...)
Affinity DataIC50: 100nMAssay Description: Baculovirus expression and purification of C. parvum phosphatidylinositol 4-kinase: The full-length coding sequence of C. parvum PI(4)K (cgd8_4500, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2022
Entry Details
WIPO WO2022079616

TargetPhosphatidylinositol 4-kinase(Cryptosporidium parvum (strain Iowa II))
Novartis

WIPO
LigandPNGBDBM533861(WO2022079616, Example 1.26 | Methyl 5-(N-methyl-3-...)
Affinity DataIC50: 100nMAssay Description: Baculovirus expression and purification of C. parvum phosphatidylinositol 4-kinase: The full-length coding sequence of C. parvum PI(4)K (cgd8_4500, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2022
Entry Details
WIPO WO2022079616

TargetPhosphatidylinositol 4-kinase(Cryptosporidium parvum (strain Iowa II))
Novartis

WIPO
LigandPNGBDBM533765(WO2022079616, Example 1.02 | tert-Butyl 5-(3-(4-ca...)
Affinity DataIC50: 100nMAssay Description: Baculovirus expression and purification of C. parvum phosphatidylinositol 4-kinase: The full-length coding sequence of C. parvum PI(4)K (cgd8_4500, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2022
Entry Details
WIPO WO2022079616

TargetPhosphatidylinositol 4-kinase(Cryptosporidium parvum (strain Iowa II))
Novartis

WIPO
LigandPNGBDBM533862(WO2022079616, Example 1.27 | Methyl 5-(3-(4-carbam...)
Affinity DataIC50: 550nMAssay Description: Baculovirus expression and purification of C. parvum phosphatidylinositol 4-kinase: The full-length coding sequence of C. parvum PI(4)K (cgd8_4500, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2022
Entry Details
WIPO WO2022079616

TargetPI3K/PI4K catalytic domain-containing protein(Cryptosporidium hominis)
Novartis

WIPO
LigandPNGBDBM533793(WO2022079616, Example 1.18 | 2-Chloro-5-(N-methyl-...)
Affinity DataIC50: 550nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2022
Entry Details
WIPO WO2022079616

TargetPI3K/PI4K catalytic domain-containing protein(Cryptosporidium hominis)
Novartis

WIPO
LigandPNGBDBM533812(WO2022079616, Example 1.19 | 2-Morpholinoethyl 2-c...)
Affinity DataIC50: 550nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2022
Entry Details
WIPO WO2022079616

TargetPI3K/PI4K catalytic domain-containing protein(Cryptosporidium hominis)
Novartis

WIPO
LigandPNGBDBM533865(WO2022079616, Example 4.1 | Methyl 2-(3-(4-carbamo...)
Affinity DataIC50: 550nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2022
Entry Details
WIPO WO2022079616

TargetPhosphatidylinositol 4-kinase(Cryptosporidium parvum (strain Iowa II))
Novartis

WIPO
LigandPNGBDBM533837(WO2022079616, Example 1.22 | Methyl 2-chloro-5-(N-...)
Affinity DataIC50: 550nMAssay Description: Baculovirus expression and purification of C. parvum phosphatidylinositol 4-kinase: The full-length coding sequence of C. parvum PI(4)K (cgd8_4500, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2022
Entry Details
WIPO WO2022079616

TargetPhosphatidylinositol 4-kinase(Cryptosporidium parvum (strain Iowa II))
Novartis

WIPO
LigandPNGBDBM533783(WO2022079616, Example 1.14 | rac-1-((Ethoxycarbony...)
Affinity DataIC50: 550nMAssay Description: Baculovirus expression and purification of C. parvum phosphatidylinositol 4-kinase: The full-length coding sequence of C. parvum PI(4)K (cgd8_4500, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2022
Entry Details
WIPO WO2022079616

TargetPI3K/PI4K catalytic domain-containing protein(Cryptosporidium hominis)
Novartis

WIPO
LigandPNGBDBM533764(WO2022079616, Example 1.01 | N-(4-cyanophenyl)-N-m...)
Affinity DataIC50: 550nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2022
Entry Details
WIPO WO2022079616

TargetPI3K/PI4K catalytic domain-containing protein(Cryptosporidium hominis)
Novartis

WIPO
LigandPNGBDBM533790(WO2022079616, Example 1.16 | Methyl 2-chloro-5-(N-...)
Affinity DataIC50: 550nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2022
Entry Details
WIPO WO2022079616

TargetPI3K/PI4K catalytic domain-containing protein(Cryptosporidium hominis)
Novartis

WIPO
LigandPNGBDBM533862(WO2022079616, Example 1.27 | Methyl 5-(3-(4-carbam...)
Affinity DataIC50: 1.00E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2022
Entry Details
WIPO WO2022079616

TargetPI3K/PI4K catalytic domain-containing protein(Cryptosporidium hominis)
Novartis

WIPO
LigandPNGBDBM533863(WO2022079616, Example 2.1)
Affinity DataIC50: 1.00E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2022
Entry Details
WIPO WO2022079616

TargetPI3K/PI4K catalytic domain-containing protein(Cryptosporidium hominis)
Novartis

WIPO
LigandPNGBDBM533771(WO2022079616, Example 1.08 | 2-Morpholinoethyl 5-(...)
Affinity DataIC50: 1.00E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2022
Entry Details
WIPO WO2022079616

TargetPI3K/PI4K catalytic domain-containing protein(Cryptosporidium hominis)
Novartis

WIPO
LigandPNGBDBM533864(WO2022079616, Example 3.1 | Methyl 2-chloro-5-(N-m...)
Affinity DataIC50: 1.00E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2022
Entry Details
WIPO WO2022079616

TargetPI3K/PI4K catalytic domain-containing protein(Cryptosporidium hominis)
Novartis

WIPO
LigandPNGBDBM533813(WO2022079616, Example 1.21 | Methyl 2-chloro-5-(N-...)
Affinity DataIC50: 1.00E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2022
Entry Details
WIPO WO2022079616

TargetPhosphatidylinositol 4-kinase(Cryptosporidium parvum (strain Iowa II))
Novartis

WIPO
LigandPNGBDBM533856(WO2022079616, Example 1.23 | Methyl 5-(3-(4-carbam...)
Affinity DataIC50: 1.00E+3nMAssay Description: Baculovirus expression and purification of C. parvum phosphatidylinositol 4-kinase: The full-length coding sequence of C. parvum PI(4)K (cgd8_4500, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2022
Entry Details
WIPO WO2022079616

TargetPI3K/PI4K catalytic domain-containing protein(Cryptosporidium hominis)
Novartis

WIPO
LigandPNGBDBM533837(WO2022079616, Example 1.22 | Methyl 2-chloro-5-(N-...)
Affinity DataIC50: 1.00E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2022
Entry Details
WIPO WO2022079616

TargetPhosphatidylinositol 4-kinase(Cryptosporidium parvum (strain Iowa II))
Novartis

WIPO
LigandPNGBDBM533857(WO2022079616, Example 1.24 | Methyl 2-chloro-5-(3-...)
Affinity DataIC50: 1.00E+3nMAssay Description: Baculovirus expression and purification of C. parvum phosphatidylinositol 4-kinase: The full-length coding sequence of C. parvum PI(4)K (cgd8_4500, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2022
Entry Details
WIPO WO2022079616

TargetPI3K/PI4K catalytic domain-containing protein(Cryptosporidium hominis)
Novartis

WIPO
LigandPNGBDBM533856(WO2022079616, Example 1.23 | Methyl 5-(3-(4-carbam...)
Affinity DataIC50: 1.00E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2022
Entry Details
WIPO WO2022079616

TargetPI3K/PI4K catalytic domain-containing protein(Cryptosporidium hominis)
Novartis

WIPO
LigandPNGBDBM533783(WO2022079616, Example 1.14 | rac-1-((Ethoxycarbony...)
Affinity DataIC50: 1.00E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2022
Entry Details
WIPO WO2022079616

TargetPI3K/PI4K catalytic domain-containing protein(Cryptosporidium hominis)
Novartis

WIPO
LigandPNGBDBM533857(WO2022079616, Example 1.24 | Methyl 2-chloro-5-(3-...)
Affinity DataIC50: 1.00E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2022
Entry Details
WIPO WO2022079616

TargetPI3K/PI4K catalytic domain-containing protein(Cryptosporidium hominis)
Novartis

WIPO
LigandPNGBDBM533860(WO2022079616, Example 1.25 | Methyl 5-(3-(4-carbam...)
Affinity DataIC50: 1.00E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2022
Entry Details
WIPO WO2022079616